DR. ELIOT FRANKLIN BATTLE, M.D.
Dermatology at Wisconsin Ave, Washington, DC
License number
DC MD33462
Category
Osteopathic Medicine
Type
Dermatology
License number
DC D0050131
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
5301 Wisconsin Ave NW SUITE 110, Washington, DC 20015
Phone
(202) 237-9292
Personal information
See more information about ELIOT FRANKLIN BATTLE at radaris.comName
Address
Phone
2800 Chesterfield Pl NW, Washington, DC 20008
Washington, DC
2737 Devonshire Pl NW, Washington, DC 20008
3301 Military Rd NW, Washington, DC 20015
5300 43Rd St NW, Washington, DC 20015
Professional information
See more information about ELIOT FRANKLIN BATTLE at trustoria.com
Owner, Cultura
Owner, Cultura
Position:
Owner at Cultura
Location:
Washington D.C. Metro Area
Industry:
Health, Wellness and Fitness
Work:
Cultura
-
Owner
Education:
Harvard Medical School 1998 - 2001
Dr. Eliot F Battle, Washington DC - MD (Doctor of Medicine)
Dr. Eliot F Battle, Washington DC - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
Cosmetic Physicians/Assocs
5301 Wisconsin Ave NW SUITE 110, Washington 20015
(202) 237-2542 (Phone)
5301 Wisconsin Ave NW SUITE 110, Washington 20015
(202) 237-2542 (Phone)
Languages:
English
Education:
Medical School
Howard University
Graduated: 1994
Howard University
Graduated: 1994
Eliot Franklin Battle, Washington DC
Eliot Franklin Battle, Washington DC
Specialties:
Dermatologist
Address:
5301 Wisconsin Ave Nw, Washington, DC 20015
Methods And Devices For Epithelial Protection During Photodynamic Therapy
Methods And Devices For Epithelial Protection During Photodynamic Therapy
US Patent:
2007017, Jul 26, 2007
Filed:
Apr 3, 2007
Appl. No.:
11/695669
Inventors:
Richard Anderson - Lexington MA, US
Bernhard Ortel - Boston MA, US
Eliot Battle - Washington DC, US
Edwin Joe - New York NY, US
Bernhard Ortel - Boston MA, US
Eliot Battle - Washington DC, US
Edwin Joe - New York NY, US
Assignee:
The General Hospital Corporation d/b/a MASSACHUSETTS GENERAL HOSPITAL - Boston MA
International Classification:
A61N 5/06
US Classification:
607088000
Abstract:
Methods for preventing damage to epithelial tissue during PDT induced using a photosensitizing agent or pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control photoactivation of the photoactive species to protect the epithelial tissue. In one embodiment, epithelial tissue surrounding a targeted treatment site can be protecting by decreasing the oxygen-content in the tissue, thereby preventing the conversion of the photosensitizer into the phototoxic species in the epithelial tissue.
Methods And Devices For Epithelial Protection During Photodynamic Therapy
Methods And Devices For Epithelial Protection During Photodynamic Therapy
US Patent:
2004025, Dec 23, 2004
Filed:
Apr 14, 2004
Appl. No.:
10/709122
Inventors:
Richard Anderson - Lexington MA, US
Bernhard Ortel - Boston MA, US
Eliot Battle - Washington DC, US
Edwin Joe - New York NY, US
Bernhard Ortel - Boston MA, US
Eliot Battle - Washington DC, US
Edwin Joe - New York NY, US
Assignee:
MASSACHUSETTS GENERAL HOSPITAL - Charlestown MA
International Classification:
A61N001/30, A61K031/555, A61K031/195
US Classification:
514/185000, 514/410000, 514/561000, 604/020000
Abstract:
Methods for preventing damage to the epidermis during PDT induced using a pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control formation of a photoactive species from a topically-applied pre-photosensitizing agent. In one embodiment, thermal inhibition is used to prevent the metabolism of a pre-photosensitizing agent in epithelial tissue surrounding a treatment site. In another embodiment, a chemical inhibitor can be applied to the epithelial tissue to inhibit the conversion of a pre-photosensitizing agent into a phototoxic species.
Methods And Devices For Epithelial Protection During Photodynamic Therapy
Methods And Devices For Epithelial Protection During Photodynamic Therapy
US Patent:
2004025, Dec 23, 2004
Filed:
Apr 14, 2004
Appl. No.:
10/709121
Inventors:
Richard Anderson - Lexington MA, US
Bernhard Ortel - Boston MA, US
Eliot Battle - Washington DC, US
Edwin Joe - New York NY, US
Bernhard Ortel - Boston MA, US
Eliot Battle - Washington DC, US
Edwin Joe - New York NY, US
Assignee:
MASSACHUSETTS GENERAL HOSPITAL - Charlestown MA
International Classification:
A61K031/555, A61K031/195, A61N001/30
US Classification:
514/185000, 514/410000, 514/561000, 604/020000
Abstract:
Methods for preventing damage to epithelial tissue during PDT induced using a photosensitizing agent or pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control photoactivation of the photoactive species to protect the epithelial tissue. In one embodiment, epithelial tissue surrounding a targeted treatment site can be protecting by decreasing the oxygen-content in the tissue, thereby preventing the conversion of the photosensitizer into the phototoxic species in the epithelial tissue.
Methods And Devices For Epithelial Protection During Photodynamic Therapy
Methods And Devices For Epithelial Protection During Photodynamic Therapy
US Patent:
8207212, Jun 26, 2012
Filed:
Dec 21, 2009
Appl. No.:
12/643089
Inventors:
Richard Rox Anderson - Boston MA, US
Bernhard Ortel - Boston MA, US
Eliot F. Battle - Washington DC, US
Edwin K. Joe - New York NY, US
Bernhard Ortel - Boston MA, US
Eliot F. Battle - Washington DC, US
Edwin K. Joe - New York NY, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61B 8/00, A01N 43/38, A01N 37/12, A01N 37/44, A61K 31/195, C07B 47/00, C07D 487/22, C07C 229/00, A61N 5/02, A61N 1/39
US Classification:
514410, 514561, 514859, 514863, 540145, 562567, 424 961, 600 2, 607 1
Abstract:
Methods for preventing damage to the epidermis during PDT induced using a pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control formation of a photoactive species from a topically-applied pre-photosensitizing agent. In one embodiment, thermal inhibition is used to prevent the metabolism of a pre-photosensitizing agent in epithelial tissue surrounding a treatment site. In another embodiment, a chemical inhibitor can be applied to the epithelial tissue to inhibit the conversion of a pre-photosensitizing agent into a phototoxic species.